(Q43540620)

24 November 2017

Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist (English)

1 reference

24 November 2017

Davis AM

1

1 reference

PubMed ID

11245826

24 November 2017

Inturrisi CE

series ordinal

2

1 reference

PubMed ID

11245826

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

894

1 reference

24 November 2017

1

1 reference

24 November 2017

150-153

1 reference

The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

Cloned glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

Pharmacological evidence for involvement of excitatory amino acids in aversive responses induced by intrathecal substance P in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

Ketamine attenuates and reverses morphine tolerance in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903325-4

10.1016/S0006-8993(00)03325-4

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11245826